Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.09.2014 | editorial

ASH 2013: constant progress: not only for B-cell neoplasms

verfasst von: Michael Steurer, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Excerpt

The 55th Annual Meeting of the American Society of Hematology (ASH) held in New Orleans was attended by 21,000 participants from over 110 countries. Despite the famous meeting place (“The Big Easy”), selecting the most relevant data out of a wealth of > 5000 abstracts and > 3000 presentations represents a major challenge. Therefore, in this issue of MEMO several experts in the field have worked through the wealth of data presented to extract the most meaningful clinical and translational data for the readers of this journal. Moreover, I would like to congratulate all of them for their excellent performance. …
Nächster Artikel The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent
Literatur
1.
Steurer M. ASH Update 2013: chronic lymphocytic leukemia and indolent lymphoma. Memo 2014;3. DOI 10.1007/s12254-014-0174-4.
2.
Burgstaller S. Myelodysplastic syndromes (MDS). Memo 2014;3. DOI 10.1007/s12254-014-0158-4.
3.
Nösslinger T. Aggressive lymphoma at ASH 2013: R-CHOP under attack? Memo 2014;3. DOI 10.1007/s12254-014-0148-6.
4.
Schmidt S. ASH 2013: short review on myeloproliferative neoplasms. Memo 2014;3. DOI 10.1007/s12254-014-0168-2.
5.
Feistritzer C, Wildner SM. Highlights of the American Society of Hematology Meeting 2013: hemostaseology. Memo 2014;3. DOI 10.1007/s12254-014-0157-5.
Metadaten
Titel
ASH 2013: constant progress: not only for B-cell neoplasms
verfasst von
Michael Steurer, MD
Publikationsdatum
01.09.2014
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2014
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-014-0173-5

Weitere Artikel der Ausgabe 3/2014

Highlights of the American Society of Hematology Meeting 2013: hemostaseology

  • short review

Myelodysplastic syndromes (MDS)

  • short review

ASH Update 2013: chronic lymphocytic leukemia and indolent lymphoma

  • short review

The role of maintenance strategies in breast cancer

  • short review

Challenges with overall survival as an endpoint for efficacy assessment in first line metastatic breast cancer randomized controlled clinical trials and the investigation of truncated overall survival as an alternative endpoint

  • special report

Molecular monitoring of minimal residual disease in acute leukemia

  • short review